Onward Medical N.V. (ONWD) - Cash Flow Conversion Efficiency

Latest as of December 2025: -0.366x

Based on the latest financial reports, Onward Medical N.V. (ONWD) has a cash flow conversion efficiency ratio of -0.366x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€-20.25 Million ≈ $-23.68 Million USD) by net assets (€55.32 Million ≈ $64.67 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Onward Medical N.V. balance sheet quality to measure how much of total assets are equity-financed.

Onward Medical N.V. - Cash Flow Conversion Efficiency Trend (2018–2025)

This chart illustrates how Onward Medical N.V.'s cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore ONWD operating cash flow to total debt to assess how comfortably operating cash covers total debt obligations.

Onward Medical N.V. Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Onward Medical N.V. ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Hup Seng Industries Bhd KLSE:5024	0.135x
Jay Bharat Maruti Limited NSE:JAYBARMARU	0.044x
Fiducian Group Ltd AU:FID	0.212x
Sinphar Pharmaceutical Co Ltd TW:1734	0.031x
Lexinfintech Holdings Ltd NASDAQ:LX	0.081x
ÜSTRA Hannoversche Verkehrsbetriebe Aktiengesellschaft F:HVB	-0.030x
Lynch Group Holdings Ltd AU:LGL	0.146x
Krsnaa Diagnostics Limited NSE:KRSNAA	0.056x

Annual Cash Flow Conversion Efficiency for Onward Medical N.V. (2018–2025)

The table below shows the annual cash flow conversion efficiency of Onward Medical N.V. from 2018 to 2025. For the full company profile with market capitalisation and key ratios, see Onward Medical N.V. (ONWD) market capitalisation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	€55.32 Million ≈ $64.67 Million	€-39.07 Million ≈ $-45.67 Million	-0.706x	-6.85%
2024-12-31	€48.05 Million ≈ $56.18 Million	€-31.76 Million ≈ $-37.13 Million	-0.661x	+63.27%
2023-12-31	€17.93 Million ≈ $20.96 Million	€-32.27 Million ≈ $-37.73 Million	-1.800x	-254.95%
2022-12-31	€52.63 Million ≈ $61.53 Million	€-26.68 Million ≈ $-31.20 Million	-0.507x	-110.94%
2021-12-31	€82.68 Million ≈ $96.67 Million	€-19.87 Million ≈ $-23.23 Million	-0.240x	-159.80%
2020-12-31	€-32.09 Million ≈ $-37.52 Million	€-12.90 Million ≈ $-15.08 Million	0.402x	-39.07%
2019-12-31	€-14.92 Million ≈ $-17.45 Million	€-9.85 Million ≈ $-11.51 Million	0.660x	-5.33%
2018-12-31	€-10.27 Million ≈ $-12.01 Million	€-7.16 Million ≈ $-8.37 Million	0.697x	--

About Onward Medical N.V.

BR:ONWD Belgium Biotechnology

Market Cap

$189.80 Million

€162.35 Million EUR

Market Cap Rank

#16684 Global

#71 in Belgium

Share Price

€2.34

Change (1 day)

+0.21%

52-Week Range

€2.33 - €5.52

All Time High

€12.90